These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The syndrome of inappropriate antidiuretic hormone: current and future management options. Sherlock M; Thompson CJ Eur J Endocrinol; 2010 Jun; 162 Suppl 1():S13-8. PubMed ID: 20164215 [TBL] [Abstract][Full Text] [Related]
6. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH). Harbeck B; Lindner U; Haas CS Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548 [No Abstract] [Full Text] [Related]
7. 'Dos and don'ts' in the management of hyponatremia. Aylwin S; Burst V; Peri A; Runkle I; Thatcher N Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050 [TBL] [Abstract][Full Text] [Related]
8. Clinical practice. The syndrome of inappropriate antidiuresis. Ellison DH; Berl T N Engl J Med; 2007 May; 356(20):2064-72. PubMed ID: 17507705 [No Abstract] [Full Text] [Related]
9. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion]. Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222 [No Abstract] [Full Text] [Related]
10. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases. Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029 [TBL] [Abstract][Full Text] [Related]
11. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm. Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057 [TBL] [Abstract][Full Text] [Related]
12. Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care. Tzoulis P; Carr H; Bagkeris E; Bouloux PM Endocrine; 2017 Feb; 55(2):539-546. PubMed ID: 27837439 [TBL] [Abstract][Full Text] [Related]
13. [SIADH and vaptans]. Decaux G Ann Endocrinol (Paris); 2012 Apr; 73(2):130-4. PubMed ID: 22537510 [TBL] [Abstract][Full Text] [Related]
14. [Etiology, diagnostics and therapy of hyponatremias]. Laczi F Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466 [TBL] [Abstract][Full Text] [Related]
15. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis. Mali P; Muduganti SR; Mujibur R; Murali N WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059 [TBL] [Abstract][Full Text] [Related]
16. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia. Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624 [TBL] [Abstract][Full Text] [Related]
17. [Hyponatraemia in elderly patient - significance, clarification and therapy]. Gosch M Dtsch Med Wochenschr; 2022 Mar; 147(6):301-305. PubMed ID: 35291034 [TBL] [Abstract][Full Text] [Related]
18. The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia. Arı H; Kahraman F; Acaban MB Turk Kardiyol Dern Ars; 2015 Apr; 43(3):284-7. PubMed ID: 25906002 [TBL] [Abstract][Full Text] [Related]
19. [Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls]. Hofmann W; Flägel K; Gosch M Z Gerontol Geriatr; 2020 Aug; 53(5):463-472. PubMed ID: 32691149 [TBL] [Abstract][Full Text] [Related]
20. Annotation on hyponatremia. Thomas TH; Morgan DB Am Heart J; 1979 Aug; 98(2):268-9. PubMed ID: 110125 [No Abstract] [Full Text] [Related] [Next] [New Search]